AlphaYouTK
Insider buying
Thomas K Equels bought $5K of AIM ImmunoTech Inc. (AIM) stock
Thomas K Equels, CEO & President of AIM ImmunoTech Inc. (AIM), bought 22,000 shares of AIM stock worth $5K, per an SEC Form 4 filed Sep 16, 2026.
It was an open-market purchase.
The trade happened on Sep 15, 2026, 1 day before it was made public.
- Traded
- Sep 15, 2026
- Disclosed
- Sep 16, 2026
- Filing delay
- 1 day
- Role
- CEO & President
- Source
- SEC Form 4
More AIM insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.